News & Updates

Low-dose CT works well for COVID-19 assessment

04/25/2020

Excerpt from the article: April 23, 2020 — Chest CT at a radiation dose under 1 mSv can accurately and rapidly assess COVID-19 infection in emergency room patients — particularly those who have had symptoms longer than 48 hours, according to a study published April 21 in Radiology: Cardiothoracic Imaging. The results are good news…

Read More

This sensor could detect COVID-19 in the air

04/24/2020

Excerpt From the Article: Researchers at the Swiss Federal Laboratory have developed a sensor that could potentially quickly and reliably detect SARS-CoV-2, the COVID-19 virus. Prior to the coronavirus spreading around the world, Jing Wang and his colleagues were researching sensors that could detect bacteria and viruses in the air. The concept of the sensor…

Read More

Anyone with a computer can help this Covid-19 project

04/17/2020

Excerpt from the article: The Washington University School of Medicine’s Folding@home project will utilise supercomputers at the Science and Technology Facilities Council (STFC) Hartree Centre to better understand protein behaviour in diseases. The project is calling on anyone with a personal computer to help out, as they can lend any unused background capacity to help…

Read More

Building a bridge to a COVID-19 vaccine

04/16/2020

Excerpt from the article: Regeneron has shared high hopes for its two candidates in the fight against COVID-19 on the first day of the four-day eyeforpharma Philadelphia virtual event. George Yancopolous, President and Chief Scientific Officer at Regeneron, revealed that the company expected to have a good idea of the prospects for Kevzara, one…

Read More

COVID-19 funding opportunities

04/15/2020

Excerpt from the article: Innovative Solutions Canada has dedicated funding to help combat current and future outbreaks of the novel coronavirus (COVID-19) and other similar threats. Our program will help support the Government of Canada’s fight against COVID-19 by funding R&D and testing prototypes in real-life settings that can help protect Canadians. Click the button…

Read More

How Mapping COVID-19 Could Help Drug Companies

04/14/2020

Excerpt from the article: When the spread of COVID-19 started to affect the University of Connecticut, the state, and the country, Ranjan Srivastava, department head for Chemical and Biomolecular Engineering, knew he had to spring into action. Drawing on his previous work in mathematically modeling how the Hepatitis B virus spreads, Srivastava realized he could…

Read More

UPMC led global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies

04/13/2020

Excerpt from the article: PITTSBURGH, April 9, 2020 – A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies, such as the anti-malarial drug hydroxychloroquine,…

Read More

Ontario Power Generation makes coronavirus face shields

04/09/2020

Excerpt from the article: “DURHAM — Front-line health-care workers dealing with the COVID-19 pandemic are getting a helping hand from Ontario Power Generation and Ontario Tech University in Oshawa. OPG is using 3D printing technology to produce plastic face shields and the company has partnered with Ontario Tech University to fast-track the production of this…

Read More

VCU doctor leading clinical trial on drug to treat COVID-19 encouraged by initial results

04/09/2020

Excerpt from the article: “RICHMOND, Va. (WRIC) — VCU Health is in the middle of conducting clinical trials for an experimental drug that could possibly treat COVID-19. Dr. Arun Sanyal, the doctor leading the trials, told 8News Tuesday that results are encouraging and it’s about improving how a patient feels, functions and survives. Remdesivir, a…

Read More

Hemarina offers its oxygen carrier molecule to fight the COVID-19 pandemic

04/08/2020

Excerpt from the Article: “Hemarina, a French biotech company, could come to the help of doctors fighting the coronavirus. The company has developed a molecule derived from marine worms, which could help people seriously affected by the COVID-19, who do not have access to respirators. The molecule called M101, binds 40 times more oxygen than…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives